| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 02/29/2012 | EP1325133B1 Bvh-a2 and bvh-a3 antigens of group b streptococcus |
| 02/29/2012 | EP1092039B1 Methods for generating highly diverse libraries |
| 02/29/2012 | CN1914223B Modified human interferon polypeptides and their uses |
| 02/29/2012 | CN1886420B Self-assembling split-fluorescent protein systems |
| 02/29/2012 | CN102365368A Method for removing viruses in high-concentration monoclonal antibody solution |
| 02/29/2012 | CN102365361A Protein having affinity for immunoglobulin, and immunoglobulin-binding affinity ligand |
| 02/29/2012 | CN102363800A Method for preparing antioxidant oligopeptide by performing ultrasonic enzymolysis on swim bladders |
| 02/29/2012 | CN102363799A Preparation method for aromatic-amino-acid-enriched antioxidant |
| 02/29/2012 | CN102363798A Preparation process for collagen sponge |
| 02/29/2012 | CN101691596B Methods of hydrolyzing soyabean protein to produce exorphins |
| 02/29/2012 | CN101586138B Process for preparing and purifying Exendin-4 from colon bacillus |
| 02/28/2012 | US8124750 Recombinant protective protein from Streptococcus pneumoniae |
| 02/28/2012 | US8124748 Cell surface glycoprotein |
| 02/28/2012 | US8124731 Optimized Fc variants and methods for their generation |
| 02/28/2012 | US8124729 Splice variants of human G-protein coupled receptor HGPRBMY29 (HGPRMBY29SV2) |
| 02/28/2012 | US8124728 CA125 gene and its use for diagnostic and therapeutic interventions |
| 02/28/2012 | US8124381 Process and materials for production of glucosamine and N-acetylglucosamine |
| 02/28/2012 | US8124378 Murine zcytor17 ligand polynucleotides |
| 02/28/2012 | US8124377 Method of producing TAT-HOXB4H |
| 02/28/2012 | US8124376 Methods for producing biological substances in pigment-deficient mutants of bacillus cells |
| 02/28/2012 | US8124374 Method of producing recombinant protein |
| 02/28/2012 | US8124373 Isomaltulose synthases, polynucleotides encoding them and uses therefor |
| 02/28/2012 | US8124372 Selective enzymatic amidation of C-terminal esters or acids of peptides |
| 02/28/2012 | US8124369 Method of cleaving DNA with rationally-designed meganucleases |
| 02/28/2012 | US8124349 Toll-like receptor assays |
| 02/28/2012 | US8124347 Photosynthetic hydrogen production from the green alga chlamydomonas reinhardth |
| 02/28/2012 | US8124104 Norovirus and sapovirus antigens |
| 02/28/2012 | US8124103 Influenza antigens, vaccine compositions, and related methods |
| 02/28/2012 | US8124093 Human cytomegalovirus neutralizing antibodies and use thereof |
| 02/28/2012 | US8124080 Human monoclonal antibody having fat-reducing effect |
| 02/28/2012 | US8124079 Anti-IGF-IR antibodies and uses thereof |
| 02/28/2012 | US8124078 Method for treating idiopathic thrombocytopenic purpura using monoclonal antibodies |
| 02/28/2012 | US8124074 Fusion proteins |
| 02/28/2012 | US8124066 Methods of using interleukin-2 mutants with reduced toxicity |
| 02/28/2012 | CA2485506C A method for in vitro molecular evolution of protein function |
| 02/28/2012 | CA2480121C Methods for increasing polypeptide production |
| 02/28/2012 | CA2417860C Novel variant egiii-like cellulase compositions |
| 02/28/2012 | CA2219361C Human antibodies derived from immunized xenomice |
| 02/23/2012 | WO2012024662A2 Expression constructs comprising fungal promoters |
| 02/23/2012 | WO2012024452A2 Modified relaxin polypeptides and their uses |
| 02/23/2012 | WO2012023614A1 Monoclonal antibody having immunosuppressive activity or fragment to which antigen thereof is bonded |
| 02/23/2012 | WO2012023580A1 Method for producing low immunogenic streptavidin having antibody bonded thereto |
| 02/23/2012 | WO2012022688A1 Method for inactivating proteases by ph change in a liquid obtained from a cell culture |
| 02/23/2012 | WO2012022040A1 Hiv-1 virus membrane fusion inhibitor and use thereof |
| 02/23/2012 | WO2003099989A3 Compositions and methods relating to breast specific genes and proteins |
| 02/23/2012 | WO2003008563A3 Improved cytochrome p450 oxygenases |
| 02/23/2012 | US20120047607 Novel Bacillus thuringiensis Gene with Coleopteran Activity |
| 02/23/2012 | US20120047606 Novel Bacillus thuringiensis Gene with Lepidopteran Activity |
| 02/23/2012 | US20120047605 Novel Bacillus thuringiensis Gene with Lepidopteran Activity |
| 02/23/2012 | US20120047586 Polypeptide having enhanced effector function |
| 02/23/2012 | US20120047585 Hco32 and hco27 and related examples |
| 02/23/2012 | US20120046229 Modified relaxin polypeptides and their uses |
| 02/23/2012 | US20120046227 Designer osteogenic proteins |
| 02/23/2012 | US20120046221 Albumin fusion proteins |
| 02/23/2012 | US20120046184 method for the selective concentration of a specific low abundance biomolecule |
| 02/23/2012 | US20120045795 Method for producing a cell capable of high-yield production of heteroproteins |
| 02/23/2012 | US20120045794 Preparation of protective antigen |
| 02/23/2012 | US20120045793 Expression constructs comprising fungal promoters |
| 02/23/2012 | US20120045777 Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses |
| 02/23/2012 | US20120045776 Monoclonal antibody ds6, tumor-associated antigen ca6, and methods of use thereof |
| 02/23/2012 | US20120045774 Lipoprotein Associated Phospholipase A2, Inhibitors Thereof and Use of the Same in Diagnosis and Therapy |
| 02/23/2012 | US20120045566 Oligosaccharide ingredient |
| 02/23/2012 | US20120045473 Biomolecule Surface Display and Uses Thereof |
| 02/23/2012 | US20120045464 Cryptosporidium parvum antigens, antibodies thereto and diagnostic and therapeutic compositions thereof |
| 02/23/2012 | US20120045458 Use of notch regulators for modulating the immune response by induction/suppression of interleukin-22 |
| 02/23/2012 | US20120045457 Nontypable haemophilus influenzae antigens |
| 02/23/2012 | US20120045447 T cell costimulating polypeptides and uses thereof |
| 02/23/2012 | US20120045443 Agonist anti-trk-c monoclonal antibodies |
| 02/23/2012 | US20120045438 Engineered anti-il-13 antibodies, compositions, methods and uses |
| 02/23/2012 | US20120045437 MONOCLONAL ANTIBODIES THAT INHIBIT THE Wnt SIGNALING PATHWAY AND METHODS OF PRODUCTION AND USE THEREOF |
| 02/23/2012 | US20120045390 Composition and Methods for the Diagnosis and Treatment of Tumor |
| 02/23/2012 | CA2808596A1 Modified relaxin polypeptides and their uses |
| 02/23/2012 | CA2807693A1 Method for inactivating proteases by ph change in a liquid obtained from a cell culture |
| 02/22/2012 | EP2420572A1 Monoclonal antibody capable of binding to specific discontinuous epitope occurring in ad1 region of human cytomegalovirus gb glycoprotein, and antigen-binding fragment thereof |
| 02/22/2012 | EP2420571A1 High expression promoter and method for producing gene product using same |
| 02/22/2012 | EP2420512A2 Anti-VEGF antibodies |
| 02/22/2012 | EP2420249A1 Vaccine immunotherapy for immune suppressed patients |
| 02/22/2012 | EP2419522A2 Methods and kits to predict therapeutic outcome of tyrosine kinase inhibitors |
| 02/22/2012 | EP1788074B1 Novel strains belonging to the genus paenibacillus and method of controlling plant disease by using these strains or culture thereof |
| 02/22/2012 | EP1740608B1 Modified human growth hormone polypeptides and their uses |
| 02/22/2012 | EP1608767B1 Optimized expression of hpv 31 l1 in yeast |
| 02/22/2012 | CN1819844B 免疫原粘附抑制剂及其制备和使用方法 Immunogen adhesion inhibitors and their preparation and use |
| 02/22/2012 | CN102361979A Peptide capable of binding to immunoglobulin |
| 02/22/2012 | CN102358755A Fusion protein capable of inhibiting tumor neovascularization and production technology thereof |
| 02/22/2012 | CN101928670B 一种抗生素的高产菌株及其制备方法和用途 An antibiotic producing strain and its preparation and use |
| 02/22/2012 | CN101348819B 酶法提取山药蛋白复合物的技术 Enzymatic extraction technology yam protein complexes |
| 02/22/2012 | CN101235406B 发酵法合成多粘菌素e的方法 Fermentation of polymyxin e Synthesis Method |
| 02/22/2012 | CN101203241B 人源化抗-cd70结合物和其应用 Humanized anti -cd70 conjugates and their application |
| 02/21/2012 | US8119775 Human anti-KIR antibodies |
| 02/21/2012 | US8119769 Complement depletion using recombinant human C-3 derivatives |
| 02/21/2012 | US8119406 System and method for production of antibodies in plant cell culture |
| 02/21/2012 | US8119396 Recombinant adenoviral vectors and applications thereof |
| 02/21/2012 | US8119383 Glycosidase enzymes |
| 02/21/2012 | US8119381 Rationally-designed meganucleases with altered sequence specificity and DNA-binding affinity |
| 02/21/2012 | US8119380 Methods and materials for making and using transgenic dicamba-degrading organisms |
| 02/21/2012 | US8119374 Nucleotide sequences of coryneform bacteria coded for proteins participating in L-serine metabolism and method for microbial production of L-serine |
| 02/21/2012 | US8119372 Method of production of L-amino acids |
| 02/21/2012 | US8119371 Process for the preparation of polymyxin B employing (PAENI) Bacillus polymyxa |
| 02/21/2012 | US8119370 Activatable recombinant neurotoxins |
| 02/21/2012 | US8119369 Human SUMO-3 for enhancing protein expression |